Clinical features of polymyalgia rheumatica and giant cell arteritis

Carlo Salvarani, Nicolò Pipitone, Annibale Versari, Gene G. Hunder

Research output: Contribution to journalArticlepeer-review


Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are inflammatory diseases that typically affect white individuals >50 years. Women are affected ĝ̂1/42g-3 times more often than men. PMR and GCA occur together more frequently than expected by chance. The main symptoms of PMR are pain and stiffness in the shoulders, and often in the neck and pelvic girdle. Imaging studies reveal inflammation of joints and bursae of the affected areas. GCA is a large-vessel and medium-vessel arteritis predominantly involving the branches of the aortic arch. The typical clinical manifestations of GCA are new headache, jaw claudication and visual loss. PMR and GCA usually remit within 6 months to 2 years from disease onset. Some patients, however, have a relapsing course and might require long-standing treatment. Diagnosis of PMR and GCA is based on clinical features and elevated levels of inflammatory markers. Temporal artery biopsy remains the gold standard to support the diagnosis of GCA; imaging studies are useful to delineate large-vessel involvement in GCA. Glucocorticoids remain the cornerstone of treatment of both PMR and GCA, but patients with GCA require higher doses. Synthetic immunosuppressive drugs also have a role in disease management, whereas the role of biologic agents is currently unclear.

Original languageEnglish
Pages (from-to)509-521
Number of pages13
JournalNature Reviews Rheumatology
Issue number9
Publication statusPublished - Sep 2012

ASJC Scopus subject areas

  • Rheumatology


Dive into the research topics of 'Clinical features of polymyalgia rheumatica and giant cell arteritis'. Together they form a unique fingerprint.

Cite this